Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic.

Antimicrobial Agents and Chemotherapy
Christian DokomajilarGrant Dorsey

Abstract

Polymorphisms in the Plasmodium falciparum pfmdr1 gene were assayed in pretreatment samples and in samples from patients reinfected following therapy with artemether-lumefantrine. The pfmdr1 alleles 86N, 184F, and 1246D significantly increased in prevalence after treatment. All samples had a single pfmdr1 copy. Treatment with artemether-lumefantrine selects for polymorphisms that may alter antimalarial drug response.

References

Jan 25, 2003·Antimicrobial Agents and Chemotherapy·Pedro V L CravoDavid Walliker
Jul 25, 2003·Antimicrobial Agents and Chemotherapy·Amy L PickardSteven R Meshnick
Feb 18, 2005·The Journal of Infectious Diseases·Christin SisowathJosé P Gil
Sep 16, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Andreas MårtenssonAnders Björkman
Oct 20, 2005·The Journal of Infectious Diseases·Anne-Catrin UhlemannSanjeev Krishna
Jan 13, 2006·Trends in Parasitology·Ian M Hastings, William M Watkins
May 3, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ric N PriceFrançois Nosten

❮ Previous
Next ❯

Citations

Jun 3, 2008·Transactions of the Royal Society of Tropical Medicine and Hygiene·Anja K DippmannFrank P Mockenhaupt
Nov 3, 2009·Nature Reviews. Microbiology·Richard T Eastman, David A Fidock
Nov 30, 2012·The New England Journal of Medicine·Jane AchanMoses R Kamya
Sep 2, 2011·The Journal of Infectious Diseases·Frederick N Baliraine, Philip J Rosenthal
Jul 5, 2012·The Journal of Antimicrobial Chemotherapy·Alexis NzilaAssad Al-Thukair
Jun 15, 2007·Antimicrobial Agents and Chemotherapy·Samuel L NsobyaPhilip J Rosenthal
Jan 13, 2010·Antimicrobial Agents and Chemotherapy·Samuel L NsobyaPhilip J Rosenthal
Mar 25, 2009·Antimicrobial Agents and Chemotherapy·Véronique ParquetBruno Pradines
Feb 24, 2011·Antimicrobial Agents and Chemotherapy·Aurélie PascualBruno Pradines
Feb 4, 2009·Antimicrobial Agents and Chemotherapy·Sant MuangnoicharoenStephen A Ward
Sep 8, 2007·Malaria Journal·Christopher V PlowePhilip J Rosenthal
Sep 14, 2011·PloS One·Pedro Eduardo FerreiraJosé Pedro Gil
Nov 21, 2012·The American Journal of Tropical Medicine and Hygiene·Anne M Vardo-ZalikGuiyun Yan
Dec 18, 2014·International Journal for Parasitology. Drugs and Drug Resistance·John OkomboLynette Isabella Ochola-Oyier
Feb 18, 2010·Critical Reviews in Toxicology·Thomas Efferth, Bernd Kaina
Dec 21, 2010·Trends in Parasitology·Xavier C DingGiovanna Raso
Mar 23, 2010·Trends in Parasitology·Carol Hopkins SibleyPascal Ringwald
Nov 29, 2007·Trends in Parasitology·Carol Hopkins SibleyChristopher V Plowe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

BioHub - Researcher Network

The Chan-Zuckerberg Biohub aims to support the fundamental research and develop the technologies that will enable physicians to cure, prevent, or manage all diseases in our childrens' lifetimes. The CZ Biohub brings together researchers from UC Berkeley, Stanford, and UCSF. Find the latest research from the CZ Biohub researcher network here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.